EDNRB and diabetes mellitus: In conclusion, we found that upregulation of ET-1 and its receptors (ETA and ETB) is an early event in the diabetic retina, the topical (eye drops) administration of bosentan prevents retinal neurodegeneration induced by diabetes not only by blocking but also by downregulating ETB receptors.